PHETA1

PHETA1 (IPIP27A/FAM109A) is an endocytic adaptor that couples the inositol 5-phosphatase OCRL1 to membrane-remodeling machinery to drive cargo trafficking through endosomes and the trans-Golgi network (PMID:21233288, PMID:26510499). It binds the C-terminal region of OCRL1 and the related phosphatase INPP5B through a conserved F&H-type motif, self-associates into homo- and heterodimers with PHETA2 (IPIP27B), and localizes to early and recycling endosomes and the TGN, where it is required for receptor recycling (PMID:21233288). Mechanistically, PHETA1 bridges OCRL1 to the F-BAR protein pacsin 2, stimulating the curvature-sensitive 5-phosphatase activity of OCRL1 and promoting scission of mannose 6-phosphate receptor-containing carriers; its loss blocks biogenesis of these trafficking intermediates (PMID:26510499). In vivo, PHETA1 acts together with OCRL to support megalin-dependent proximal tubule endocytosis (PMID:34673953) and is required for craniofacial chondrocyte maturation, where it restrains cathepsin K activity, and the patient-derived R6C variant exacerbates these phenotypes in a dominant-negative manner (PMID:32152089).

1. 2011 High

   Established PHETA1 as an OCRL1/INPP5B-binding adaptor by defining its physical partners, oligomeric state, compartmental localization, and a functional requirement in receptor recycling.

   Evidence Co-IP, imaging, and knockdown receptor recycling assays in cultured cells

   PMID:21233288

   Open questions at the time

   • Did not define the enzymatic consequence of binding OCRL1
   • Did not identify membrane-remodeling effectors
2. 2015 High

   Answered how PHETA1 acts mechanistically by showing it bridges OCRL1 to pacsin 2, stimulating OCRL1 5-phosphatase activity and enabling scission of MPR carriers.

   Evidence Co-IP, in vitro 5-phosphatase assay, and loss-of-function trafficking biogenesis readouts

   PMID:26510499

   Open questions at the time

   • Structural basis of the OCRL1-PHETA1-pacsin 2 assembly not resolved
   • In vivo relevance not yet tested
3. 2019 Low

   Linked PHETA1 to glomerular biology by detecting association with OCRL1 and the slit-diaphragm protein CD2AP in podocytes.

   Evidence Co-IP/co-association in cultured podocytes

   PMID:31811534

   Open questions at the time

   • Single Co-IP in one cell type without reciprocal validation
   • No functional rescue or mutagenesis
   • Functional consequence for slit-diaphragm maintenance untested
4. 2019 Medium

   Demonstrated evolutionary conservation of the adaptor-phosphatase module, showing F&H-motif binding of IPIP27 orthologs to the OCRL ortholog Dd5P4 controls membrane deformation across endocytic stations.

   Evidence Genetic knockout, co-depletion epistasis, and live imaging in Dictyostelium

   PMID:31216233

   Open questions at the time

   • Conservation inferred from a model organism
   • Direct mapping to mammalian PHETA1 functions not established in this study
5. 2020 High

   Provided in vivo and disease-relevant function, showing PHETA1/2 loss disrupts renal endocytosis and ciliogenesis and impairs chondrocyte maturation via cathepsin K dysregulation, with the R6C patient variant acting dominant-negatively.

   Evidence Zebrafish knockout/morphant, imaging, cathepsin K inhibitor rescue, and patient-variant overexpression

   PMID:32152089

   Open questions at the time

   • Molecular link between PHETA1 trafficking role and cathepsin K regulation not defined
   • Mechanism of R6C dominant-negative action unresolved
6. 2022 High

   Placed PHETA1 directly in the OCRL pathway in the proximal tubule by phenocopying OCRL loss for fluid-phase and cargo uptake, megalin abundance, and endosome morphology, with epistasis confirming co-function.

   Evidence Zebrafish knockout, cargo uptake assays, immunostaining, and co-depletion/rescue epistasis

   PMID:34673953

   Open questions at the time

   • Mechanism by which PHETA1 loss reduces megalin abundance unresolved
   • Mammalian proximal tubule confirmation not addressed

• How PHETA1 trafficking function mechanistically connects to its tissue-specific outputs (cathepsin K regulation, megalin stability, slit-diaphragm maintenance) and the structural basis of dominant-negative variants remain open.
• No structural model of the OCRL1-PHETA1-pacsin 2 complex
• Causal chain from endosomal scission defects to ECM/cathepsin K phenotypes undefined
• Human disease causation rests on a single patient variant